Current Signal Transduction Therapy
Volume 17, 3 Issues, 2022
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
Contents
Current Signal Transduction Therapy , Volume 2 - Number 2
Targeting Neurotrophic Signal Transduction Pathways in the Treatment of Mood Disorders
, 2(2): 101 - 110Todd D. Gould and Husseini K. Manji
DOI: 10.2174/157436207780619518
Smad-Signaling in Mammary Gland Development and Tumorigenesis
, 2(2): 111 - 120Vandana Gupta, Arunthathi Thiagalingam and Shyamala Maheswaran
DOI: 10.2174/157436207780619482
Nitric Oxide: Friendly Rivalry in Tuberculosis
, 2(2): 121 - 128Sangita Mukhopadhyay, Shiny Nair and Seyed E. Hasnain
DOI: 10.2174/157436207780619536
Potential Utilization of Bystander / Abscopal-Mediated Signal Transduction Events in the Treatment of Solid Tumors
, 2(2): 129 - 143Matthew E. Peters, Mohammed M. Shareef, Seema Gupta, Marianna Zagurovskaya-Sultanov, Munira Kadhim, Mohammed Mohiuddin and Mansoor M. Ahmed
DOI: 10.2174/157436207780619509
Mathematical Modeling of the Cancer Cell â s Control Circuitry: Paving the Way to Individualized Therapeutic Strategies
, 2(2): 145 - 155R. P. Araujo, E. F. Petricoin and L. A. Liotta
DOI: 10.2174/157436207780619545
Oncogene-Directed Therapies as Modulators of Cancer Coagulopathy, Angiogenesis and Tumor-Vascular Interface
, 2(2): 157 - 163Janusz Rak, Chloe Milsom, Linda May and Joanne Yu
DOI: 10.2174/157436207780619473
Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours
, 2(2): 165 - 173P. Tagliaferri, P. Tassone, A. Pietragalla, M. S. Rotundo, V. Barbieri, A. Budillon, M. Caraglia, F. S. Costanzo and S. Venuta
DOI: 10.2174/157436207780619491
Blocking Apoptotic Intracellular Signaling Cascades with Cell-Permeable Peptides
, 2(2): 175 - 179Azel Zine, Alain Uziel, Jacques Beckmann and Christophe Bonny
DOI: 10.2174/157436207780619527
Editor-in-Chief
Jingxuan Yang
Department of Medicine
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)
Biography
Department of Medicine
The University of Oklahoma Health Science Center
Oklahoma City, OK
Biography
Biography of Jingxuan Yang
Dr. Yang obtained a doctorate (Ph.D.) in Molecular Biology & Biochemistry from Chinese Academy of Med. Sci. and Peking Union Med. College (CAMS & PUMC), Beijing, China. Currently Dr. Yang is an assistant professor in the University of Oklahoma Health Sciences Center. He has published more than 30 scientific publications and served as active editorial board member of Scientific Reports.
Dr. Yang is currently the Editor-in-Chief of this journal (Current Signal Transduction Therapy), published by Bentham Science Publishers.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Special Offers
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net